LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SLGN
Silgan Holdings Inc.
SLGN has a slight edge over LCID overall, supported by lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SLGN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
SLGN's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SLGN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 10x | $40.71 | — |
| Cheap | 14x | $34.15 | -16% |
| Fair | 16x | $38.73 | -4.9% |
| Current | 16x | $40.71 | — |
| Expensive | 18x | $44.51 | +9.3% |
Historical ranges are pointers, not guarantees.
SLGN's PE is in its fair range at 16x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SLGN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect SLGN's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SLGN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.03 | +62% |
| Q3 2026 | $2.49 | -15% |
| Q2 2026 | $2.56 | -8.9% |
| Q1 2026 | $2.67 | -0.7% |
| Q4 2025 | $2.70 | +4.7% |
| Q3 2025 | $2.94 | +6.5% |
| Q2 2025 | $2.81 | -1.4% |
| Q1 2025 | $2.69 | -5.6% |
| Q4 2024 | $2.58 | -13% |
SLGN has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SLGN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SLGN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +1.6% |
| Q2 2026 | $1.6B | +6.8% |
| Q1 2026 | $1.6B | +6.4% |
| Q4 2025 | $1.5B | +4.1% |
| Q3 2025 | $2B | +15% |
| Q2 2025 | $1.5B | +11% |
| Q1 2025 | $1.5B | +11% |
| Q4 2024 | $1.4B | +5.3% |
SLGN's revenue has grown year over year for eight quarters in a row: $2B last quarter, up 1.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.1% | -0.3 points |
| Q2 2026 | 6.3% | -1.4 points |
| Q1 2026 | 5.4% | -0.6 points |
| Q4 2025 | 3.6% | +0.2 points |
| Q3 2025 | 7.4% | +0.2 points |
| Q2 2025 | 7.7% | +0.4 points |
| Q1 2025 | 6% | +0.4 points |
| Q4 2024 | 3.5% | -2.8 points |
SLGN has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SLGN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $264.7M | +1.5% |
| Q2 2026 | -$258.5M | +$35.7M |
| Q1 2026 | -$882M | -$115.7M |
| Q4 2025 | $1.2B | +41% |
| Q3 2025 | $260.8M | +3.3% |
| Q2 2025 | -$294.2M | -$258.9M |
| Q1 2025 | -$766.3M | -$143.3M |
| Q4 2024 | $865M | -16% |
SLGN has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SLGN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +151K shares |
| 1 year | -0.8% | -860K shares |
| 3 years | -2.6% | -2.8M shares |
| 5 years | -4.7% | -5.3M shares |
| Available history | -5% | -5.6M shares |
SLGN has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $7.8M |
| Q4 2025 | $8.7M |
| Q3 2025 | $59.3M |
| Q2 2025 | — |
| Q1 2025 | $6.9M |
| Q4 2024 | $1.6M |
SLGN spent $17M buying back its own shares over the past year, down 76% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SLGN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.9x | High |
| Q2 2026 | 6.2x | High |
| Q1 2026 | 5.8x | High |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 6.3x | High |
| Q2 2025 | 7.0x | High |
| Q1 2025 | 6.6x | High |
| Q4 2024 | 5.3x | High |
SLGN's net debt is about 5.9 years of its operating earnings (EBITDA), down from 6.3 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SLGN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.1 | Neutral |
| Stochastic | 64.4 | Neutral |
SLGN's weekly RSI is 51 (neutral) and its Stochastic is 64 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SLGN PE vs Consumer Cyclical Sector
| Metric | SLGN | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 9.3% below |
| PE % | 62 | 47 | 15 pts above |
SLGN is trading at 16x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SLGN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.2 | 6.6% above |
| 20 week MA | $40.8 | 0.2% below |
| 50 week MA | $41.3 | 1.5% below |
| 100 week MA | $45.4 | 10% below |
| 200 week MA | $46.5 | 12% below |
SLGN has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SLGN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.1 | $36.9 | +19% |
| 2021 | $36.9 | $41.1 | +12% |
| 2022 | $41.1 | $52.8 | +28% |
| 2023 | $52.8 | $45.3 | -14% |
| 2024 | $45.3 | $52.6 | +16% |
| 2025 | $52.6 | $40.9 | -22% |
| 2026 YTD | $40.9 | $40.7 | -0.4% |
SLGN has the edge over LCID on returns for 2026, with the stronger performance.